Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lonza Biologics, Inc. | Portsmouth, NH, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyFeb 6, 2026 · 8 inspections |
| PCI San Diego, Inc. | San Diego, CA, United States | Makes it and tests it | Problems found, fixed voluntarilyMay 9, 2025 · 11 inspections |
| AndersonBrecon Inc. | Rockford, IL, United States | Packages it and labels it | No problems foundAug 19, 2026 · 11 inspections |
| Labcorp Early Development Laboratories Inc. | Greenfield, IN, United States | Tests it | Problems found, fixed voluntarilyJul 25, 2025 · 3 inspections |
| Nelson Laboratories, LLC | Salt Lake City, UT, United States | Tests it | Problems found, fixed voluntarilyJun 2, 2023 · 6 inspections |
| West Services and Solutions LLC | Exton, PA, United States | Tests it | No problems foundMar 9, 2026 · 5 inspections |
Product details
- Generic drug
- Obiltoxaximab: every company that makes it
- Form
- solution, intravenous
- Strength
- 100 mg per 1 mL
- Approval
- BLA BLA125509
- On the market since
- Mar 18, 2016
- Package NDCs
69604-204-02- Official label
- DailyMed (National Library of Medicine), updated Sep 14, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?